Remote, machine health monitoring services reduce the need for on-site visits.
Augury introduced new features and services for machine health monitoring in industrial facilities, the company announced in a May 6, 2020 press release. The company added guided self-installation capabilities so customers can implement machine health monitoring in new facilities even when access may be restricted. This feature allows customers to install Augury monitoring components themselves, guided remotely by Augury personnel.
“Our customers are telling us that machine health and remote collaboration matter more than ever to them, and they want to expand their deployment of digital solutions in these challenging times,” said Saar Yoskovitz, CEO of Augury, in the press release.
New features include customized notifications and Threads Tagging, which works similarly to other collaboration tools by allowing users to notify team members or subject matter experts if they want their attention on a certain question or issue. The conversations are preserved in the platform to help users in future similar situations and as a way to share best practices across the entire team, the company said in the press release.
The Early Insights feature uses artificial intelligence to deliver alerts more quickly and provide richer context around the alert to help solve problems more quickly. According to the press release, the feature helps reduce risk for machines that are degrading quickly.
Automated connectivity alerts, extended battery life, and power over ethernet for monitoring components eliminates gaps in monitoring while reducing the need for on-site visits by employees and contractors.
Source: Augury
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.